Prepare for the ICH E6 (R3) transition. We provide gap analysis, training, and process redesign to align your clinical trials with the new risk-based quality management standards..
The shift to ICH E6 (R3) requires a fundamental update to trial oversight and data governance. Adamas Consulting helps you interpret and implement these changes, focusing on Quality by Design (QbD) and fit-for-purpose technology. We guide your teams through the transition, ensuring your QMS remains compliant and efficient in a modernized regulatory landscape.
Overview of ICH E6 (R3)
ICH E6 (R3) is the latest revision of the International Council for Harmonisation (ICH) Good Clinical Practice (GCP) guideline. It aims to modernize clinical trial conduct by promoting a more flexible, risk-based, and participant-centered approach while maintaining data integrity and subject safety. Compared to previous versions, R3 emphasizes quality by design, tailored trial oversight, proportionality in trial processes, and the responsible use of technology.
Featured Resources
For a deeper dive into the ICH E6(R3) guidelines, check out our latest expert insights.
Webinar
ADAMAS Consulting’s webinar, “GCP ICH E6 R3 Unveiled: Navigating the Evolving Roles of Sponsors and CROs,” provides invaluable insights into the evolving landscape of Good Clinical Practice (GCP) guidelines.
Case Study
Our latest case study highlights how ADAMAS Consulting supported a leading pharmaceutical company in proactively identifying high-risk sites during a global Phase III oncology trial—aligning with ICH E6 (R3) guidelines.
Guide
Our Views
Let's Start a Conversation